Oncopharmpod

Recent Landmarks (CLEOPATRA, Keynote189)

Informações:

Synopsis

Recent updated survival analyses for CLEOPATRA and Keynote-189 (6:45) require some historical context to truly see their impact. Finally, #AskOncoPharm returns (15:05) with a listener question about infusion rates when restarting daratumumab.

Share